Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prevest DenproBOM:543363 +0.78%84 Current Ratio is 14.91 as of Mar. 2026, which is 53% above its 10-year median of 9.76. GuruFocus rates BOM:543363 with a GF Score™ of 84/100 and a GF Value™ of ₹622.13 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Prevest Denpro ranks better than 97.3% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Prevest Denpro's current ratio for the quarter that ended in Mar. 2026 was 14.91.
Prevest Denpro has a current ratio of 14.91. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Prevest Denpro's Current Ratio or its related term are showing as below:
BOM:543363'
s Current Ratio Range Over the Past 10 Years
Min: 3 Med: 9.76 Max: 14.91
Current: 14.91
During the past 8 years, Prevest Denpro's highest Current Ratio was 14.91. The lowest was 3.00. And the median was 9.76.
BOM:543363's Current Ratio is ranked better than 97.3% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs BOM:543363: 14.91
Prevest Denpro (BOM:543363) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Prevest Denpro Current Ratio Related Terms
Prevest Denpro Current Ratio Historical Data
* Premium members only.
The historical data trend for Prevest Denpro's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543363 vs ISRG, BDX, MDLN: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, Prevest Denpro's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prevest Denpro Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prevest Denpro's Current Ratio distribution charts can be found below:
* The bar in red indicates where Prevest Denpro's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prevest Denpro (BOM:543363) has a Current Ratio of 14.91 as of Mar. 2026. This is 53% above median its historical median of 9.76. Over the past decade, Prevest Denpro's Current Ratio has ranged from 3.00 to 14.91. According to the industry distribution chart, Prevest Denpro ranks #23 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 2.7%.
Is Prevest Denpro's Current Ratio too high?
Prevest Denpro's current Current Ratio of 14.91 is 53% above median its 10-year median of 9.76. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 14.91. The Medical Devices & Instruments industry median Current Ratio is 2.49. Prevest Denpro's value of 14.91 is 498.8% above this industry median. Based on the distribution chart, Prevest Denpro ranks #23 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Prevest Denpro has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prevest Denpro ranks #23 out of 853 companies for Current Ratio. This places Prevest Denpro in the top 3% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.49. Prevest Denpro's value of 14.91 is 498.8% above this benchmark. Historically, Prevest Denpro's own Current Ratio has ranged from 3.00 to 14.91 over the past decade. While the company's 10-year median is 9.76 vs. the industry median of 2.49, Prevest Denpro has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prevest Denpro's current Current Ratio of 14.91 is 498.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prevest Denpro's current Current Ratio is 14.91, which is 53% above median its own 10-year median of 9.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹622.13, compared to a current price of ₹390.00 — trading 37.3% below its estimated fair value. The current Current Ratio is 14.91, which is 53% above median its 10-year median of 9.76 and 498.8% above the Medical Devices & Instruments industry median of 2.49. Prevest Denpro's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current Current Ratio is 14.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prevest Denpro (BOM:543363) Overvalued in 2026?
Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued.
The current stock price of ₹390.00 is trading 37.3% below its estimated GF Value™ of ₹622.13.
GuruFocus considers Prevest Denpro to be Possible Value Trap.
Key valuation signals for BOM:543363:
Current Ratio: 14.91 (53% above median its 10-year median of 9.76)
GF Value™: ₹622.13 vs. price of ₹390.00 (37.3% below fair value)
Industry Position: 498.8% above the Medical Devices & Instruments median (#23 of 853)
No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
84GF Score
Get the complete analysis for BOM:543363
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543363 has been successfully added to your 
